CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- 8-K Event Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Other events
- 8-K Event Shareholder vote results
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement · Unregistered share sale
- 10-K/A Report 10-K/A
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-K/A Report 10-K/A
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
Page 7 of 20 · 384 filings